FLOWEL PLUS

This brand name is authorized in Nigeria.

Active ingredients

The drug FLOWEL PLUS contains a combination of these active pharmaceutical ingredients (APIs):

1	Dutasteride UNII O0J6XJN02I - DUTASTERIDE
	Dutasteride reduces circulating levels of dihydrotestosterone (DHT) by inhibiting both type 1 and type 2, 5α-reductase isoenzymes which are responsible for the conversion of testosterone to DHT.
	Read more about Dutasteride
2	Tamsulosin UNII 11SV1951MR - TAMSULOSIN HYDROCHLORIDE
	Tamsulosin binds selectively and competitively to post-synaptic α1-adrenoreceptors, prevailingly their subtypes designated α1A and α1D. Thus relaxation of smooth muscles of the prostate and urethra is achieved, which leads to a reduction of tonus and an improvement of the urinary flow.
	Read more about Tamsulosin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9016	Capsule	FLOWEL PLUS CAPSULES CAP 0.5 mg; 0.4 mg 110	FLOWEL PLUS CAPSULES TAMSULOSIN + DUTASTERIDE Tamsulosin HCI USP 0.4MG Dutasteride 0.5mg Excipients Q.S Hypromellose (HPMC E5) BP Mannitol BP Sucrose BP Crospovidone BP Ethyle Cellulose BP Diethyle Pthalate BP B4-9016 Drugs Imported Products 110 Prescription Only Medicine (POM) 24/05/2023 SUPERIOR PHARMACEUTICALS LIMITED, 9B, ROBINSON GBAGI STREET, AJAO ESTATE 8029403780 superiorpharmang@gmail.com ANTILA LIFESCIENCES PVT.LTD @ STALLION LABORATORIES PVT. LTD, C1B, 305, 2&3, GIDC KERALA (BAVLA) , DIST: AHMEDABAD-328 220, GUJARAT, INDIA, India	31/08/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G04CA52	Tamsulosin and dutasteride	G Genito urinary system and sex hormones → G04 Urologicals → G04C Drugs used in benign prostatic hypertrophy → G04CA Alpha-adrenoreceptor antagonists
Discover more medicines within G04CA52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9016